Filtering by:
Cancer UpdatesNew Drug Reduces Recurrence Risk for Some Women With Early-Stage Breast Cancer
Research presented at the San Antonio Breast Cancer Symposium may result in a new standard of care for some people with HER2 positive, early stage breast cancer.
FDA Approves First Biosimilar for Non-Hodgkin Lymphoma
The US Food and Drug Administration (FDA) has approved Truxima (rituximab-abbs), the first biosimilar drug to treat adults with some types of non-Hodgkin lymphoma.
FDA Approves Vitrakvi (Larotrectinib) for Tumors With Certain Genetic Change
For the second time, the US Food and Drug Administration (FDA) has approved a drug to treat tumors with a specific genetic change regardless of the type of cancer. Vitrakvi (larotrectinib) is for adults and children with solid tumors that test positive for NTRK genes, which can help cancerous tumors grow.
FDA Approves 2 Drugs for Acute Myeloid Leukemia (AML)
The US Food and Drug Administration (FDA) has approved 2 new drugs, Daurismo (glasdegib) and Venclexta (venetoclax), to treat people newly diagnosed with acute myeloid leukemia (AML) who are not candidates for intensive chemotherapy.
FDA Proposes Regulations as Teen E-Cigarette Use Skyrockets 78% in 1 Year
Use of e-cigarettes (also known as vaping) by high school students has jumped 78% since last year, according to the US Centers for Disease Control and Prevention (CDC).
New HHS Physical Activity Guidelines Include Americans as Young as Age 3
For the first time, the US Department of Health and Human Services (HHS) is recommending that children as young as age 3 be physically active every day.
Adolescent and Young Adult Cancer Survival Rates Increase When Re-evaluated
A new way of looking at the data of adolescents and young adults (AYAs) with cancer shows survival rates among this age group are much better than previously thought.
Cigarette Smoking at Record Low Among American Adults
The percentage of American cigarette smokers in 2017 hit 14%, its lowest point since the National Health Interview Survey (NHIS) first started tracking smoking statistics in 1965.
